Dogan et al. [65] reported elevated levels of inflammatory markers, such as interleukin 1beta, in newly diagnosed T1DM patients, as well as in DM progression, implying that systemic inflammation may play a role in the disease’s development and complications. The gene discussed is IL1B; the disease is type 1 diabetes mellitus.